Skip to main content
Back to Valor Equity Partners

Valor Equity Partners's Therapeutics Portfolio

Browse 3 Therapeutics companies funded by Valor Equity Partners. See funding amounts, founder contacts, and investment details.

Therapeutics Companies
3
Total Funding in Therapeutics
$361.0M

Therapeutics Portfolio Companies (3)

Export
Health CareMedicalPharmaceuticalTherapeutics

Holobiome is an owner and operator of a therapeutic company intended to treat diseases of the enteric and central nervous systems.

Cambridge, United States
July 2026
$10.0M
Seed

Founder Contacts

41,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyLife ScienceMedicalTherapeutics

Evozyne is a generative AI company that focuses on therapeutic discovery and drug development.

Chicago, United States
September 2023
$81.0M
Series B

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyHealth CarePharmaceuticalTherapeutics

Emalex Biosciences is a biotech startup that develops new treatments for central nervous system disorders.

Chicago, United States
November 2022
$270.0M
Series D

Founder Contacts

41,000+ verified contacts

Explore Valor Equity Partners's Full Portfolio

View all companies funded by Valor Equity Partners across every industry and funding stage.

View Full Valor Equity Partners Portfolio